Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small-pool high-yield factor VIII production.

C T Smit Sibinga

    Critical Reviews in Clinical Laboratory Sciences
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Improving hemophilia care requires better Factor VIII (FVIII) production. New methods enhance FVIII recovery, reducing plasma pool sizes and disease transmission risks for patient safety.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.

    Annals of hematology·2002
    Same author

    Risk management: an important tool for improving quality.

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2001
    Same author

    Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion.

    Vox sanguinis·2000
    Same author

    Preparation of leukocyte-poor platelet concentrates via a short, hard spin of a pool of buffy coats.

    Vox sanguinis·2000
    Same author

    Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.

    Bone marrow transplantation·2000
    Same author

    Haemovigilance systems.

    Vox sanguinis·1999
    Same journal

    Indirect methods for the verification of reference intervals in laboratory medicine.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Sustainability and waste reduction in clinical laboratories.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Aptamer-based biosensing strategies for influenza virus detection: a systematic and critical review of electrochemical and optical platforms.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Advancing patient safety through laboratory quality indicators in clinical pathology.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Blood biomarkers for the diagnosis of chorioamnionitis following preterm premature rupture of membranes: a systematic review and meta-analysis of studies since 2020.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Single cell mechanodeformation signatures as early biomarkers for hematological malignancies.

    Critical reviews in clinical laboratory sciences·2026
    See all related articles

    Area of Science:

    • Biotechnology
    • Hematology
    • Biopharmaceutical Manufacturing

    Background:

    • Hemophilia A treatment relies on purified Factor VIII (FVIII) concentrates.
    • Current FVIII production methods are inefficient, recovering only 10-20% of usable protein.
    • Large plasma pools increase the risk of pathogen transmission.

    Purpose of the Study:

    • To review current FVIII production methodologies.
    • To discuss the impact of plasma pool size on FVIII supply and safety.
    • To explore small-pool approaches and future developments in FVIII recovery.

    Main Methods:

    • Review of existing literature on FVIII production techniques.
    • Analysis of conventional and novel FVIII recovery methods.
    • Discussion of plasma pool size implications in biopharmaceutical manufacturing.

    Related Experiment Videos

    Main Results:

    • Conventional FVIII production necessitates large plasma pools due to low recovery rates.
    • Novel techniques like crush-thaw, chromatography, and precipitation improve FVIII recovery.
    • Reduced pool sizes enhance the safety and potentially the supply of FVIII concentrates.

    Conclusions:

    • Optimizing FVIII production is crucial for hemophilia care.
    • Technological advancements in FVIII recovery are key to reducing plasma pool sizes.
    • Future developments should focus on efficient and safe FVIII manufacturing to mitigate risks and improve availability.